FEATURED EVENTS

FEATURED NEWS

Wolfgang Bergmeier, PhD

2 weeks ago

Wolfgang Bergmeier appointed to Haima Therapeutics Scientific Advisory Board

Haima Therapeutics, a pre-clinical biotechnology company focused on developing platelet-inspired therapies to mitigate bleeding dysfunctions, announced today the appointment of Wolfgang Bergmeier to its Scientific Advisory Board (SAB). Dr. Bergmeier is a world-renowned scientist and key opinion leader in platelet biology, hemostasis, and thrombosis. He is currently a Professor of Biochemistry and Biophysics at The …

Read more